The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
Open accessAbstract
This selection from the NCCN Guidelines for Ovarian Cancer focuses on the less common ovarian histopathologies (LCOHs), because new algorithms were added for LCOHs and current algorithms were revised for the 2016 update. The new LCOHs algorithms include clear cell carcinomas, mucinous carcinomas, and grade 1 (low-grade) serous carcinomas/endometrioid epithelial carcinomas. The LCOHs also include carcinosarcomas (malignant mixed Müllerian tumors of the ovary), borderline epithelial tumors (also known as low malignant potential tumors), malignant sex cord-stromal tumors, and malignant germ cell tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Computed Tomography — An Increasing Source of Radiation Exposure
Brenner, D. J., & Hall, E. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra072149 · Cited by 8,748
Egner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
Bristow, R. E., Tomacruz, R. S., Armstrong, D. K., Trimble, E. L., & Montz, F. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.5.1248 · Cited by 2,312
Self-citationAmerican Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
Lee, S. J., Schover, L. R., Partridge, A. H., Patrizio, P., Wallace, W. H., Hagerty, K., Beck, L. N., Brennan, L. V., & Oktay, K. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5888 · Cited by 2,048
WHO classification of tumours of female reproductive organs
Kurman, R. J., Carcangiu, M. L., Herrington, C. S., & Young, R. H. (2014) · International Agency for Research on Cancer eBooks · Cited by 1,966
Ledermann, J. A., Raja, F. A., Fotopoulou, C., Gonzalez-Martin, A., Colombo, N., & Sessa, C. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt333 · Cited by 1,104
Piccart, M. J. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.699 · Cited by 981
Pearce, C. L., Templeman, C., Rossing, M. A., Lee, A., Near, A. M., Webb, P. M., Nagle, C. M., Doherty, J. A., Cushing-Haugen, K. L., Wicklund, K. G., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70404-1 · Cited by 939
Rebbeck, T. R., Kauff, N. D., & Domchek, S. M. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn442 · Cited by 939
Recent progress in the diagnosis and treatment of ovarian cancer
Jelovac, D., & Armstrong, D. K. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20113 · Cited by 765
Self-citationvan der Burg, M. E. L., van Lent, M., Buyse, M., Kobierska, A., Colombo, N., Favalli, G., Lacave, A. J., Nardi, M., Renard, J., & Pecorelli, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321002 · Cited by 705
Granulosa Cell Tumor of the Ovary
Schumer, S. T., & Cannistra, S. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.019 · Cited by 674
Grading Ovarian Serous Carcinoma Using a Two-Tier System
Malpica, A., Deavers, M. T., Lu, K., Bodurka, D. C., Atkinson, E. N., Gershenson, D. M., & Silva, E. G. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200404000-00009 · Cited by 670
Self-citationGenetic/Familial High-Risk Assessment: Breast and Ovarian
Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., Garber, J. E., Goorha, S., Gruber, S. B., Hampel, H., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0043 · Cited by 646
Vergote, I., De Brabanter, J., Fyles, A., Bertelsen, K., Einhorn, N., Sevelda, P., Gore, M. E., Kærn, J., Verrelst, H., Sjövall, K., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03590-x · Cited by 623
Simple ultrasound-based rules for the diagnosis of ovarian cancer
Timmerman, D., Testa, A. C., Bourne, T., Ameye, L., Jurkovic, D., Van Holsbeke, C., Paladini, D., Van Calster, B., Vergote, I., Van Huffel, S., et al. (2008) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.5365 · Cited by 613
Prat, J. (2012) · Virchows Archiv · doi:10.1007/s00428-012-1203-5 · Cited by 602
Chi, D. S., Eisenhauer, E. L., Zivanovic, O., Sonoda, Y., Abu-Rustum, N. R., Levine, D. A., Guile, M. W., Bristow, R. E., Aghajanian, C., & Barakat, R. R. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.03.018 · Cited by 591
The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial Origin
Seidman, J. D., Horkayne-Szakaly, I., Haiba, M., Boice, C. R., Kurman, R. J., & Ronnett, B. M. (2004) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000101080.35393.16 · Cited by 554
Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer
Rebbeck, T. R., Mitra, N., Wan, F., Sinilnikova, O. M., Healey, S., McGuffog, L., Mazoyer, S., Chenevix-Trench, G., Easton, D. F., Antoniou, A. C., et al. (2015) · JAMA · doi:10.1001/jama.2014.5985 · Cited by 521
McCluggage, W. G. (2011) · Pathology · doi:10.1097/pat.0b013e328348a6e7 · Cited by 497
High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors
Einhorn, L. H., Williams, S. D., Chamness, A., Brames, M. J., Perkins, S. M., & Abonour, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067749 · Cited by 496
Smith, R. A., Manassaram-Baptiste, D., Brooks, D., Cokkinides, V., Doroshenk, M., Saslow, D., Wender, R. C., & Brawley, O. W. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21212 · Cited by 478
du Bois, A., Quinn, M., Thigpen, T., Vermorken, J., Avall-Lundqvist, E., Bookman, M., Bowtell, D., Brady, M., Casado, A., Cervantes, A., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi961 · Cited by 465
Smith, R. A., Manassaram‐Baptiste, D., Brooks, D., Doroshenk, M., Fedewa, S., Saslow, D., Brawley, O. W., & Wender, R. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21261 · Cited by 451
Salani, R., Backes, F. J., Fung Kee Fung, M., Holschneider, C. H., Parker, L. P., Bristow, R. E., & Goff, B. A. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.03.008 · Cited by 428
Zhang, S., Royer, R., Li, S., McLaughlin, J. R., Rosen, B., Risch, H. A., Fan, I., Bradley, L., Shaw, P. A., & Narod, S. A. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.01.020 · Cited by 423
Kondagunta, G. V., Bacik, J., Donadio, A., Bajorin, D., Marion, S., Sheinfeld, J., Bosl, G. J., & Motzer, R. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.19.638 · Cited by 418
Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients
Earle, C. C., Schrag, D., Neville, B. A., Yabroff, K. R., Topor, M., Fahey, A., Trimble, E. L., Bodurka, D. C., Bristow, R. E., Carney, M., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj019 · Cited by 416
Optimal primary surgical treatment for advanced epithelial ovarian cancer
Elattar, A., Bryant, A., Winter-Roach, B. A., Hatem, M., & Naik, R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007565.pub2 · Cited by 403
Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
Köbel, M., Kalloger, S. E., Huntsman, D. G., Santos, J. L., Swenerton, K. D., Seidman, J. D., & Gilks, C. B. (2010) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181c042b6 · Cited by 398
Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor.
Loehrer, P. J., Gonin, R., Nichols, C. R., Weathers, T., & Einhorn, L. H. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2500 · Cited by 397
Van Gorp, T., Cadron, I., Despierre, E., Daemen, A., Leunen, K., Amant, F., Timmerman, D., De Moor, B., & Vergote, I. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606092 · Cited by 354
Eisenhauer, E. L., Abu‐Rustum, N. R., Sonoda, Y., Levine, D. A., Poynor, E. A., Aghajanian, C. A., Jarnagin, W. R., DeMatteo, R. P., D'Angelica, M. I., Barakat, R. R., et al. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.06.028 · Cited by 351
Nichols, C. R., Catalano, P. J., Crawford, E. D., Vogelzang, N. J., Einhorn, L. H., & Loehrer, P. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1287 · Cited by 348
Horwich, A., Sleijfer, D. T., Fosså, S. D., Kaye, S. B., Oliver, R. T., Cullen, M. H., Mead, G. M., de Wit, R., de Mulder, P. H., Dearnaley, D. P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1844 · Cited by 333
Management of Ovarian Stromal Cell Tumors
Colombo, N., Parma, G., Zanagnolo, V., & Insinga, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.1005 · Cited by 326
New insights into ovarian cancer pathology
Prat, J. (2012) · Annals of Oncology · doi:10.1093/annonc/mds300 · Cited by 317
Moore, R. G., Miller, M. C., Disilvestro, P., Landrum, L. M., Gajewski, W., Ball, J. J., & Skates, S. J. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318224fce2 · Cited by 308
Lancaster, J. M., Powell, C. B., Chen, L.-M., & Richardson, D. L. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.09.009 · Cited by 298
Self-citationACOG Practice Bulletin No. 103: Hereditary Breast and Ovarian Cancer Syndrome
(2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181a106d4 · Cited by 281
Diagnosis, Treatment, and Follow-Up of Borderline Ovarian Tumors
Fischerova, D., Zikan, M., Dundr, P., & Cibula, D. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0139 · Cited by 279
Dennis, S., Musa, F., Dao, F., Zivanovic, O., Sonoda, Y., Leitão, M. M., Levine, D. A., Gardner, G. J., Abu‐Rustum, N. R., & Barakat, R. R. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.08.014 · Cited by 277
Mackay, H. J., Brady, M. F., Oza, A. M., Reuss, A., Pujade-Lauraine, E., Swart, A. M., Siddiqui, N., Colombo, N., Bookman, M. A., Pfisterer, J., et al. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181dd0110 · Cited by 271
Schilder, J. M., Thompson, A. M., DePriest, P. D., Ueland, F. R., Cibull, M. L., Kryscio, R. J., Modesitt, S. C., Lu, K. H., Geisler, J. P., Higgins, R. V., et al. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6805 · Cited by 263
Self-citationMRI, CT, and PET/CT for Ovarian Cancer Detection and Adnexal Lesion Characterization
Iyer, V. R., & Lee, S. I. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.09.3522 · Cited by 263
Meinhold-Heerlein, I., Fotopoulou, C., Harter, P., Kurzeder, C., Mustea, A., Wimberger, P., Hauptmann, S., & Sehouli, J. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-016-4035-8 · Cited by 261
LANCASTER, J., BETHANPOWELL, C., KAUFF, N., CASS, I., CHEN, L., LU, K., MUTCH, D., BERCHUCK, A., KARLAN, B., & HERZOG, T. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.09.031 · Cited by 251
Self-citationPrat, J. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000917 · Cited by 224
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer
Morrison, J., Haldar, K., Kehoe, S., & Lawrie, T. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005343.pub3 · Cited by 223
Adherence to Treatment Guidelines for Ovarian Cancer as a Measure of Quality Care
Bristow, R. E., Chang, J., Ziogas, A., & Anton-Culver, H. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182922a17 · Cited by 222
Satoh, T., Hatae, M., Watanabe, Y., Yaegashi, N., Ishiko, O., Kodama, S., Yamaguchi, S., Ochiai, K., Takano, M., Yokota, H., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.8617 · Cited by 211
Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum
Gershenson, D. M., Sun, C. C., Iyer, R. B., Malpica, A. L., Kavanagh, J. J., Bodurka, D. C., Schmeler, K., & Deavers, M. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.02.037 · Cited by 210
Self-citationMeinhold-Heerlein, I., Bauerschlag, D., Hilpert, F., Dimitrov, P., Sapinoso, L. M., Orlowska-Volk, M., Bauknecht, T., Park, T.-W., Jonat, W., Jacobsen, A., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208298 · Cited by 205
McCluggage, W. G., Judge, M. J., Clarke, B. A., Davidson, B., Gilks, C. B., Hollema, H., Ledermann, J. A., Matias-Guiu, X., Mikami, Y., Stewart, C. J., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.77 · Cited by 202
Marchetti, C., De Felice, F., Palaia, I., Perniola, G., Musella, A., Musio, D., Muzii, L., Tombolini, V., & Panici, P. B. (2014) · BMC Women's Health · doi:10.1186/s12905-014-0150-5 · Cited by 200
Management of Borderline Ovarian Neoplasms
Cadron, I., Leunen, K., Van Gorp, T., Amant, F., Neven, P., & Vergote, I. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8076 · Cited by 195
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-11-201212040-00539 · Cited by 195
Castellucci, P., Perrone, A. M., Picchio, M., Ghi, T., Farsad, M., Nanni, C., Messa, C., Meriggiola, M. C., Pelusi, G., Al-Nahhas, A., et al. (2007) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3281afa256 · Cited by 192
van Leeuwen, F. E., Klip, H., Mooij, T. M., van de Swaluw, A. M. G., Lambalk, C. B., Kortman, M., Laven, J. S. E., Jansen, C. A. M., Helmerhorst, F. M., Cohlen, B. J., et al. (2011) · Human Reproduction · doi:10.1093/humrep/der322 · Cited by 190
Molina, R., Escudero, J. M., Augé, J. M., Filella, X., Foj, L., Torné, A., Lejarcegui, J., & Pahisa, J. (2011) · Tumor Biology · doi:10.1007/s13277-011-0204-3 · Cited by 179
Kennedy, A. W., & Hart, W. R. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960715)78:2<278::aid-cncr14>3.0.co;2-t · Cited by 175
The diagnostic value of PET/CT for primary ovarian cancer—A prospective study
RISUM, S., HOGDALL, C., LOFT, A., BERTHELSEN, A., HOGDALL, E., NEDERGAARD, L., LUNDVALL, L., & ENGELHOLM, S. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.11.022 · Cited by 171
No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting
Jacob, F., Meier, M., Caduff, R., Goldstein, D., Pochechueva, T., Hacker, N., Fink, D., & Heinzelmann-Schwarz, V. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.02.022 · Cited by 165
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary
Okamoto, A., Glasspool, R. M., Mabuchi, S., Matsumura, N., Nomura, H., Itamochi, H., Takano, M., Takano, T., Susumu, N., Aoki, D., et al. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000289 · Cited by 164
Patterns and Progress in Ovarian Cancer Over 14 Years
Chan, J. K., Cheung, M. K., Husain, A., Teng, N. N., West, D., Whittemore, A. S., Berek, J. S., & Osann, K. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000231680.58221.a7 · Cited by 163
SGO White Paper on Ovarian Cancer: Etiology, Screening and Surveillance
Schorge, J. O., Modesitt, S. C., Coleman, R. L., Cohn, D. E., Kauff, N. D., Duska, L. R., & Herzog, T. J. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.06.003 · Cited by 163
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine and Ovarian Carcinosarcoma
Berton-Rigaud, D., Devouassoux-Shisheboran, M., Ledermann, J. A., Leitao, M. M., Powell, M. A., Poveda, A., Beale, P., Glasspool, R. M., Creutzberg, C. L., Harter, P., et al. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000228 · Cited by 162
Self-citationBarnhill, D. R., Kurman, R. J., Brady, M. F., Omura, G. A., Yordan, E., Given, F. T., Kucera, P. R., & Roman, L. D. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2752 · Cited by 159
Malpica, A., Deavers, M. T., Tornos, C., Kurman, R. J., Soslow, R., Seidman, J. D., Munsell, M. F., Gaertner, E., Frishberg, D., & Silva, E. G. (2007) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31803199b0 · Cited by 159
Gilbert, L., Basso, O., Sampalis, J. S., Karp, I., Martins, C., Feng, J., Piedimonte, S., Quintal, L., Ramanakumar, A. V., TAKEFMAN, J. E., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70333-3 · Cited by 155
Lee, I.-H., Choi, C. H., Hong, D. G., Song, J. Y., Kim, Y. J., Kim, K. T., Lee, K. W., Park, I. S., Bae, D. S., & Kim, T. J. (2011) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2011.22.3.188 · Cited by 154
Fertility preservation in young women with epithelial ovarian cancer
Wright, J. D., Shah, M. M., Mathew, L., Burke, W. M., Culhane, J. F., Goldman, N. A., Schiff, P. B., & Herzog, T. J. (2009) · Cancer · doi:10.1002/cncr.24461 · Cited by 150
Fagotti, A., Vizzielli, G., Iaco, P. D., Surico, D., Buda, A. A., Mandato, V. D., Petruzzelli, F., Ghezzi, F., Garzarelli, S., Mereu, L., et al. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.07.016 · Cited by 149
Magrina, J. F., Zanagnolo, V. L., Noble, B. N., Kho, R. M., & Magtibay, P. M. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.11.045 · Cited by 148
Hinton, S., Catalano, P. J., Einhorn, L. H., Loehrer, P. J., Kuzel, T. M., Vaughn, D. J., & Wilding, G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.158 · Cited by 146
Hereditary Breast and Ovarian Cancer Syndrome
Simon, M. S., & Petrucelli, N. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-416-2_25 · Cited by 145
Serous ovarian tumors of low malignant potential with peritoneal implants
Gershenson, D. M., & Silva, E. G. (1990) · Cancer · Cited by 138
Self-citationSherman, M. E., PIEDMONTE, M. R., Mai, P. L., Ioffe, O. B., Ronnett, B. M., Le, L. V., Ivanov, I., Bell, M. C., Blank, S. V., DiSilvestro, P., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.1987 · Cited by 135
(2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31821477db · Cited by 134
Development of an Ovarian Cancer Symptom Index: Possibilities for Earlier Detection
Goff, B. A., Mandel, L. S., Drescher, C. W., Urban, N. D., Gough, S., Schurman, K. M., Patras, J., MAHONY, B. S., & Andersen, M. R. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000265905.84107.45 · Cited by 128
Bristow, R. E., Chang, J. J., Ziogas, A., Campos, B., Chávez, L. R., & Anton‐Culver, H. (2015) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2015.01.056 · Cited by 121
Schneider, D. T., Calaminus, G., Reinhard, H., Gutjahr, P., Kremens, B., Harms, D., & Göbel, U. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.832 · Cited by 120
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mucinous Ovarian Carcinoma
Ledermann, J. A., Luvero, D., Shafer, A., O’Connor, D., Mangili, G., Friedlander, M. L., Pfisterer, J., Mirza, M. R., Kim, J., Alexandre, J., et al. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000296 · Cited by 118
Romagnolo, C., Leon, A. E., Fabricio, A. S. C., Taborelli, M., Polesel, J., Pup, L. D., Steffan, A., Cervo, S., Ravaggi, A., Zanotti, L., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.01.016 · Cited by 113
Reitsma, W., de Bock, G. H., Oosterwijk, J. C., Bart, J., Hollema, H., & Mourits, M. J. E. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.07.021 · Cited by 111
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Sex Cord Stromal Tumors
Ray-Coquard, I. L., Brown, J., Harter, P., Provencher, D. M., Fong, P. C. C., Maenpaa, J. U., Ledermann, J. A., Emons, G., Rigaud, D. B., Glasspool, R. M., et al. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000249 · Cited by 109
Madore, J., Ren, F., Filali‐Mouhim, A., Sanchez, L. M., Köbel, M., Tonin, P. N., Huntsman, D. D., Provencher, D. M., & Mes‐Masson, A. (2009) · The Journal of Pathology · doi:10.1002/path.2659 · Cited by 108
Pejovic, T. B., & Nezhat, F. R. (2011) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2011.07.013 · Cited by 107
The Fallopian Tube as the Origin of High Grade Serous Ovarian Cancer: Review of a Paradigm Shift
Reade, C. J., Mcvey, R., Tone, A. A., Finlayson, S. J., McAlpine, J. N., Fung‐Kee‐Fung, M., & Ferguson, S. E. (2014) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30659-9 · Cited by 103
Vandenput, I., CALSTER, B. V., Capoen, A., Leunen, K., Berteloot, P., Neven, P., Moerman, P., Vergote, I. B., & Amant, F. C. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605157 · Cited by 97
Thigpen, J. T. (2009) · Yearbook of Oncology · doi:10.1016/s1040-1741(09)79358-3 · Cited by 92
Rechsteiner, M., Zimmermann, A., Wild, P. J., Caduff, R. F., von Teichman, A., Fink, D. A., Moch, H., & Noske, A. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.08.004 · Cited by 91
Protein Biomarkers of Ovarian Cancer: The Forest and The Trees
Nolen, B. M., & Lokshin, A. E. (2011) · Future Oncology · doi:10.2217/fon.11.135 · Cited by 87
How Relevant Are ACOG and SGO Guidelines for Referral of Adnexal Mass?
Dearking, A. C., Aletti, G. D., McGree, M. E., Weaver, A. L., Sommerfield, M.-K., & Cliby, W. A. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000267198.25223.bc · Cited by 85
Sato, S., Itamochi, H., Kigawa, J., Oishi, T., Shimada, M., Sato, S., Naniwa, J., Uegaki, K., Nonaka, M., & Terakawa, N. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.01065.x · Cited by 81
Carcinosarcoma of the ovary: Natural history, patterns of treatment, and outcome
George, E. M., Herzog, T. J., Neugut, A. I., Lu, Y., Burke, W. M., Lewin, S. N., Hershman, D. L., & Wright, J. D. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.06.034 · Cited by 77
Gourley, C., Farley, J. H., Provencher, D. M., Pignata, S., Mileshkin, L., Harter, P., Maenpaa, J. U., Kim, J., Pujade-Lauraine, É., Glasspool, R. M., et al. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000257 · Cited by 76
Self-citationCurrent management of ovarian carcinosarcoma
Mano, M. S., Rosa, D. D., de Azambuja, E., Ismael, G., Braga, S. A., D’Hondt, V., Piccart, M. J., & Awada, A. H. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00760.x · Cited by 76
Thigpen, J. T. (2011) · Yearbook of Medicine · doi:10.1016/s0084-3873(11)00214-8 · Cited by 75
Vergote, I. B., Trope, C. G., Amant, F. C., Ehlen, T., Reed, N. S., & Casado, A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.9785 · Cited by 74
Domchek, S. M., Friebel, T. M., Garber, J. E., Isaacs, C. J., Matloff, E. T., Eeles, R. A., Evans, D. G., Rubinstein, W. S., Singer, C. F., Rubin, S. C., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0799-x · Cited by 69
Gurumurthy, M., Bryant, A., & Shanbhag, S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006912.pub2 · Cited by 65
Laparoscopy and Ovarian Cancer: A Paradigm Change in the Management of Ovarian Cancer?
Liu, C. S., Nagarsheth, N. P., & Nezhat, F. R. (2009) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2009.01.007 · Cited by 63
Molecular Characterization of 103 Ovarian Serous and Mucinous Tumors
Vereczkey, I., Serester, O., Dobos, J., Gallai, M., Szakács, O., Szentirmay, Z., & Tóth, E. (2010) · Pathology & Oncology Research · doi:10.1007/s12253-010-9345-8 · Cited by 63
Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening
Walsh, C., Blum, A., Walts, A. E., Alsabeh, R., Tran, H., Koeffler, H. P., & Karlan, B. Y. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.11.021 · Cited by 62
The management of borderline epithelial tumors of the ovary
Burger, C. W., Prinssen, H. M., Baak, J. P. A., Wagenaar, N., & Kenemans, P. (2000) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.2000.010003181.x · Cited by 59
Screening for ovarian cancer in the general population
Gentry‐Maharaj, A., & Menon, U. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2011.11.006 · Cited by 55
AlHilli, M. M., Long, H. J., Podratz, K. C., & Bakkum-Gamez, J. N. (2011) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2011.01698.x · Cited by 40
Self-citationYoshida, A., Derchain, S., Pitta, D. R., Andrade, L. A. L. D. A., & Sarian, L. O. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.01.023 · Cited by 39
Eberlein, T. J. (2011) · Yearbook of Surgery · doi:10.1016/j.ysur.2011.02.014 · Cited by 39
Finch, A., Beiner, M. E., Lubiński, J., Lynch, H. T., Møller, P., Rosen, B. P., Murphy, J., Ghadirian, P., Friedman, E., Foulkes, W. D., et al. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000251480.69322.50 · Cited by 38
Salvage chemotherapy for recurrent germ cell cancer.
Nichols, C. R., Roth, B. J., Loehrer, P. J., Williams, S. D., & Einhorn, L. H. (1994) · PubMed · Cited by 36
Growing Teratoma Syndrome of the Ovary after Fertility-Sparing Surgery and Successful Pregnancy
Matsushita, H., Arai, K., Fukase, M., Takayanagi, T., & Ikarashi, H. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000273205 · Cited by 28
Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes
Nakonechny, Q. B., & Gilks, C. B. (2016) · Surgical pathology clinics · doi:10.1016/j.path.2016.01.003 · Cited by 26
ACR Appropriateness Criteria® Clinically Suspected Adnexal Mass
Harris, R. D., Javitt, M. C., Glanc, P., Brown, D. L., Dubinsky, T. J., Harisinghani, M. G., Khati, N. J., Kim, Y. B., Mitchell, D. G., Pandharipande, P. V., et al. (2013) · Ultrasound Quarterly · doi:10.1097/ruq.0b013e3182814d9b · Cited by 25
Cytoreductive surgery for advanced ovarian cancer: quo vadis?
Schorge, J. O., Garrett, L. A., & Goodman, A. (2011) · PubMed · Cited by 21
(2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-11-201212040-00540 · Cited by 20
Update on nonhormonal approaches to menopausal management.
Jenkins, M., & Sikon, A. L. (2008) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.75.suppl_4.s17 · Cited by 16
Current management of menopausal symptoms in cancer patients.
Barton, D. L., Loprinzi, C. L., & Gostout, B. S. (2002) · PubMed · Cited by 15
(2000) · doi:10.1002/1097-0142(20000715)89:2
Cited by
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., Brawley, O. W., & Wender, R. C. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21392 · Cited by 719
CA125 and Ovarian Cancer: A Comprehensive Review
Charkhchi, P., Cybulski, C., Gronwald, J., Wong, F. O., Narod, S. A., & Akbari, M. R. (2020) · Cancers · doi:10.3390/cancers12123730 · Cited by 602
Patel, H. K., & Bihani, T. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.12.012 · Cited by 499
Kleih, M., Böpple, K., Dong, M., Gaißler, A., Heine, S., Olayioye, M. A., Aulitzky, W. E., & Essmann, F. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2081-4 · Cited by 422
Kim, S. I., Lee, M., Kim, H. S., Chung, H. H., Kim, J.-W., Park, N. H., & Song, Y.-S. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0511-7 · Cited by 75
Metadata
- Authors
- Morgan, R. J., Armstrong, D. K., Alvarez, R. D., Bakkum-Gamez, J. N., Behbakht, K., Chen, L.-M., Copeland, L., Crispens, M. A., DeRosa, M., Dorigo, O., Gershenson, D. M., Gray, H. J., Hakam, A., Havrilesky, L. J., Johnston, C., Lele, S., Martin, L., Matulonis, U. A., O'Malley, D. M., Penson, R. T., Percac-Lima, S., Pineda, M., Plaxe, S. C., Powell, M. A., Ratner, E., Remmenga, S. W., Rose, P. G., Sabbatini, P., Santoso, J. T., Werner, T. L., Burns, J., & Hughes, M.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2016-09
- Volume
- 14
- Issue
- 9
- Pages
- 1134-1163
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2569695585
- Cited by
- 311
- References
- 121
- FWCI
- 41.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.